Chapel Hill, NC, United States of America

Ronit Freeman

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Northwestern University. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ronit Freeman

Introduction

Ronit Freeman is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of peptide amphiphiles, particularly in the development of nanofibers for regenerative therapy. His work exemplifies the intersection of chemistry and biomedical engineering.

Latest Patents

Freeman holds a patent for "PEGylated peptide amphiphile nanofibers and methods of use." This patent details the use of peptide amphiphiles (PAs), specifically PEGylated PAs, which can be assembled into nanofibers. These nanofibers may incorporate growth factor proteins that bind to specific sequences on the nonionic PAs. Additionally, the patent discusses the inclusion of charged peptide amphiphiles that can also be bound to growth factor proteins. The methods outlined in this patent have potential applications in regenerative therapy.

Career Highlights

Freeman is affiliated with Northwestern University, where he continues to advance research in his field. His innovative work has garnered attention for its potential to improve therapeutic strategies in regenerative medicine.

Collaborations

Freeman has collaborated with esteemed colleagues such as Jacob A. Lewis and Samuel I. Stupp. Their combined expertise contributes to the advancement of research in peptide amphiphiles and their applications.

Conclusion

Ronit Freeman's contributions to the field of peptide amphiphiles and nanofibers highlight his role as an influential inventor. His patent and ongoing research at Northwestern University pave the way for advancements in regenerative therapy.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…